QRS Duration and Prediction of Mortality in Patients Undergoing Risk Stratification for Ventricular Arrhythmias Combined Cardiac Resynchronization and Implantable Cardioversion Defibrillation in ...

Patients with recent-onset atrial fibrillation commonly undergo immediate restoration of sinus rhythm by pharmacologic or electrical cardioversion. However, whether immediate restoration of sinus ...

Direct current cardioversion for symptomatic atrial fibrillation or flutter is feasible and safe in patients implanted with the Watchman left atrial appendage (LAA) occlusion device, even in the ...

The conventional treatment strategy for patients with atrial fibrillation who are to undergo electrical cardioversion is to prescribe warfarin for anticoagulation for three weeks before cardioversion.

Aside from patient factors, a number of factors may influence the immediate success of cardioversion, that is, a complete failure to cardiovert. These include electrode placement, shock polarity, ...

Please provide your email address to receive an email when new articles are posted on . Sinus rhythm was restored in an effective, safe and rapid manner using drug-shock or shock-only strategies among ...

PHILADELPHIA -- For atrial fibrillation (Afib) patients with obesity, a second set of defibrillation pads for dual direct current cardioversion safely improved the success of the procedure, a ...

Atrial fibrillation (AFib) is a kind of irregular heartbeat, or arrhythmia. A problem with the electrical signals that control your heart’s pumping action causes it to beat too fast in a pattern that ...

The drug-shock strategy was more effective for patients experiencing atrial fibrillation for the first time and for patients younger than 70 years, the researchers said. Both the anti-arrhythmia drug ...

Hubner and colleagues in the UK have recently described a simplified cardioversion service that has significantly reduced waiting times at their center. They have introduced intravenous midazolam ...

In the TEE (+) group, LAAT was observed in 26 patients (7.18%). None of the patients had a thromboembolic event within the first month of follow-up. In this observational study, we investigated ...

Medtronic has warned that one of the models in its Vanta range of implantable neurostimulators for pain relief may stop working if the patient is given cardioversion therapy to restore a normal heart ...